Overview
The global Eubiotics Market (https://market.us/report/eubiotics-market/) was valued at USD 7.9 billion in 2025 and is projected to reach USD 16.7 billion by 2035, growing at a CAGR of 7.8% during 2026–2035. Asia Pacific dominated the market with a 46.1% share, generating USD 3.63 billion in revenue in 2025. According to the Eubiotics Market report, increasing adoption of probiotics, prebiotics, organic acids, essential oils, enzymes, and other natural feed additives is improving gut health, feed conversion efficiency, animal productivity, and reducing dependence on antibiotic growth promoters.
Market growth is supported by expanding livestock production, with FAO reporting global meat production of 373 million tonnes in 2024, up 1.4% from 2023, led by poultry and bovine meat. Rising poultry, swine, cattle, and aquaculture production is driving eubiotics adoption, while AI-powered predictive microbiome analysis, automated feed formulation, and real-time gut monitoring are accelerating targeted synbiotic development, improving feed efficiency and supporting sustainable livestock production.
Key Takeaways
The Global Eubiotics Market was valued at USD 7.9 billion in 2025.
The market is projected to grow at a CAGR of 7.8% and is estimated to reach USD 16.7 billion by 2035.
On the basis of products, Probiotics hold the largest market share by product at 40.5%.
Solid formulations dominate the market with a 68.4% share, significantly outperforming liquids.
On the basis of application, Gut Health is the leading application, accounting for 38.6% of the market.
Poultry Feed represents the largest consumer segment, driving 40.3% of the market share.
The Asia Pacific region is the global leader, commanding 46.1% of the total market.
Eubiotics Market Segmentation
Product Analysis
Probiotics represents dominant Segment in the Market.
Probiotics account for 40.5% of the global eubiotics market revenue, making them the leading product segment. Their dominance is driven by the ability of Bacillus spores to withstand high feed-processing temperatures, while multi-strain formulations containing Lactobacilli, Bifidobacterium, and Streptococcus improve gut health and maintain efficacy. The fastest-growing trend is the development of smart blends combining probiotics, prebiotics, and plant-based ingredients. Supported by AI and microbiome sequencing, these customized formulations have reduced product development timelines from five years to less than 24 months.
Form Analysis
Solid is a significant form in Eubiotics Market.
Solid formulations hold the largest market share at 68.4%, primarily due to their 18–36 months shelf life compared with 6–12 months for liquid products. Advanced beadlet technology protects active ingredients from pelleting temperatures of up to 90°C, ensuring stability during industrial feed processing for poultry, swine, and ruminants. Meanwhile, liquid formulations are projected to register the fastest growth, supported by automated water-dosing systems, precision dosing technologies, feed spray applications, and increasing adoption in poultry and aquaculture operations.
End Use Analysis
Eubiotics Are Mostly Utilized in the Poultry Feed.
Poultry feed represents the largest end-use segment, accounting for 40.3% of market revenue. Eubiotics are commonly used as antibiotic alternatives in broiler and layer production, with approximately 500 grams per metric ton of feed added to improve feed conversion efficiency. The short broiler production cycle of 35–42 days also delivers faster returns for producers. Aquatic feed is expected to witness the fastest growth through 2035, driven by expanding aquaculture, which now supplies more than half of global fish production, increasing adoption of Bacillus-based probiotics, antibiotic-free farming practices, and improved aquatic encapsulation technologies.
Application Analysis
Eubiotics Are the Most Widely Used for Gut Health.
Gut health is the leading application of eubiotics, accounting for 38.6% of the market. Eubiotics improve intestinal villi development, enhance nutrient absorption, reduce pathogen invasion, lower disease treatment costs, and support consistent weight gain, making them increasingly important as antibiotic growth promoters are phased out. The immunity segment is projected to grow the fastest, driven by the fact that nearly 70% of an animal's immune cells are located in the gut. As a result, producers are increasingly using yeast-based eubiotics to strengthen natural immunity and reduce the risk of pathogens such as Salmonella, helping meet stringent global food safety standards.
Key Market Segments
By Product
Probiotics
Lactobacilli
Bifidobacterum
Streptococcus
Others
Prebiotics
Fructo-oligosaccharides (FOS)
Inulin
Galacto-Oligosaccharides (GOS)
Mannan-Oligosaccharides (MOS)
Others
Organic Acids
Phytogenic
Others
By Form
Liquid
Solid
By Application
Gut Health
Immunity
Yield
Others
By End Use
Cattle Feed
Poultry Feed
Swine Feed
Aquatic Feed
Others
Driver Analysis
AMR-control driven replacement of antibiotic growth promoters
The growing emphasis on controlling antimicrobial resistance (AMR) is increasing the adoption of eubiotics as alternatives to antibiotic growth promoters. According to the FAO, probiotics, prebiotics, enzymes, acidifiers, plant extracts, essential oils, yeast, and competitive exclusion products are recognized substitutes. With global livestock antimicrobial consumption reaching 63,151 tonnes in 2010, the replacement opportunity remains significant. A 2025 FAO/Codex report found that 60.8% of Pakistan’s poultry respondents preferred probiotics, 21.7% favored organic acids, and 60.8% used these alternatives prophylactically, reflecting their growing role in routine livestock management.
Restraint Analysis
Feed-cost inflation crowding out additives
Increasing feed costs are limiting eubiotics adoption, as producers prioritize essential feed ingredients. In 2026, higher soybean prices raised production costs, while India's soybean meal prices increased from USD 0.59/kg to USD 0.74/kg within a month, a 25% rise. Although eubiotics account for only 0.5%–2.0% of feed costs, uncertain returns have led to lower inclusion rates, delayed reformulations, and pricing pressure, reducing market CAGR by an estimated 1.4 percentage points in poultry and swine production.
Opportunity Analysis
Integrated antibiotic-reduction bundles
Integrating eubiotics with biosecurity, vaccination, diagnostics, and performance guarantees presents a major growth opportunity. The FAO reports that only 42 countries have livestock antimicrobial-use monitoring systems, despite global antimicrobial consumption reaching 63,151 tonnes in 2010. Studies show Bacillus-based probiotics can reduce post-weaning diarrhea in pigs by 30% and broiler mortality by 6%–8%, enabling suppliers to achieve 3%–5% price premiums, increase customer spending by 15%–20%, generate an additional USD 250–500 million in revenue, and add about 2.1 percentage points to CAGR over the next 2–4 years.
Top comments (0)